Frequently Asked Questions
Supporting Global Surveillance of Infectious Diseases

Getting Started
Have questions? Try our video tutorial!

Video tutorial - (49 minutes)

Documentation

* All of these documents were installed with WHONET. By default, you can find them at C:\WHONET\Docs\.

WHONET 5.6 & WHONET 2017

WHONET 1 - Getting Started - 1,081 KB
WHONET 2 - Laboratory configuration - 414 KB
WHONET 3 - Data entry - 652 KB
WHONET 4 - Data analysis I - 671 KB
WHONET 5 - Data analysis II - 523 KB
WHONET 6 - Expert systems - 579 KB
WHONET 7 - Macros and Excel reports - 815 KB
WHONET 8 - Cluster detection and SaTScan - 287 KB
How to run? - Antibiogram - 580 KB

WHONET 2017

WHONET for GLASS - English - 287 KB
WHONET for GLASS - Arabic - 287 KB
WHONET for GLASS - Chinese - 287 KB
WHONET for GLASS - French - 287 KB
WHONET for GLASS - Russian - 287 KB
WHONET for GLASS - Spanish - 287 KB

WHONET WEB

View our requirements documentation


BacLink

BacLink 1 - Getting Started - 50 KB
BacLink 2 - Excel, text, other applications - 1,143 KB
BacLink 3 - Laboratory Information Systems - 68 KB
BacLink 4 - Cerner Classic - 291 KB
BacLink 5 - Meditech Magic - 142 KB
BacLink 6 - Microscan - 134 KB
BacLink 7 - Vitek - 122 KB

Background

WHONET is an information system developed to support The World Health Organization's (WHO) goal of global surveillance of bacterial resistance to antimicrobial agents. Microbiologists, clinicians and infection control workers may use its software to enhance monitoring of drug resistance in their hospitals and communities and to merge their files into national, regional, and global networks for surveillance of drug resistance. WHONET software can be installed on personal computers and be configured for the locations of the patients a laboratory serves and for the antimicrobial agents it tests. The program accepts susceptibility test results and allows printing of reports and logbooks and retrieval of data. If the laboratory already has a computerized reporting system, a translation program can be created to download the laboratory's files into WHONET. Either way, the microbiologists and other infectious disease specialists gain new analytical tools to monitor and manage susceptibility test quality and the spread of drug resistance locally and outside their area.

WHONET can also analyze stored data. From a single screen, a WHONET user selects the type of analysis to run, the species of bacteria to analyze, the subsets of isolates to include (e.g., all, isolates from urine only, and isolates resistant to gentamicin and from certain locations), and the antimicrobial agents and period to examine. Types of analyses include percentage of data categorized as resistant, intermediate, or susceptible by standard or other breakpoints; distributions of test measurements (zone diameter, minimal inhibitory concentration) in the form of histograms; scatterplots comparing measurements for different agents or methods for the same isolates; and line listings of isolates grouped by combinations of agents to which they are resistant (antibiotypes) to trace distinctive strains. Isolates with uncommon antibiotypes can also be flagged on entry so that they may be rechecked while still available, and local outbreaks can be detected early.

Although test results are entered and monitored locally on software configured for local use, they are filed in a universal file format so that any copy of the program can analyze the files of any laboratory. This feature has enabled groups of users in 10 countries to set up passive surveillance systems by pooling and analyzing their files collaboratively. WHONET assists such initiatives by providing file encryption options to ensure confidentiality before data are pooled and analyzed.

Ongoing local analysis by local workers is the foundation of the system. It detects local problems in testing, which no laboratory can avoid entirely, and thus improves the overall quality of the files. It delineates local spread of drug-resistant strains, which aids infection control and can explain and correct uncommon prevalence of certain types of drug resistance at certain sites. It allows local workers to distinguish their problems from those of other sites and focus on infection control or antimicrobial use that might be related to those problems.

Expansion of the system has been recommended by the WHO Scientific Working Group on Monitoring and Management of Bacterial Resistance to Antimicrobial Agents.




Copyright © 2017 | WHO Collaborating Centre for Surveillance of Antimicrobial Resistance | 75 Francis St. Boston, MA 02115 | help@whonet.org